These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18664651)

  • 1. Re: Should observational studies be a thing of the past?
    Weiss NS
    J Natl Cancer Inst; 2008 Aug; 100(15):1117; author reply 1117-8. PubMed ID: 18664651
    [No Abstract]   [Full Text] [Related]  

  • 2. Should observational studies be a thing of the past?
    Pritchard KI
    J Natl Cancer Inst; 2008 Apr; 100(7):451-2. PubMed ID: 18364499
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer and hormonal therapy.
    Conner P; Lundström E; von Schoultz B
    Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen therapy and breast cancer.
    Gambrell RD
    Int J Fertil; 1990; 35(4):202-4. PubMed ID: 1977710
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Wood C; Cline M
    J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867
    [No Abstract]   [Full Text] [Related]  

  • 6. The Million Women Study: a licence to kill other investigations?
    van der Mooren MJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):3-5. PubMed ID: 15036701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 9. [New reports on estrogen therapy. Increased risk of breast cancer; no effects on Alzheimer disease].
    Flam F
    Lakartidningen; 2000 May; 97(18):2166-9. PubMed ID: 10850046
    [No Abstract]   [Full Text] [Related]  

  • 10. The Million Women Study, an additional observational study with the implications and limits of an observational study.
    Braendle W
    Maturitas; 2003 Oct; 46(2):101-2. PubMed ID: 14559376
    [No Abstract]   [Full Text] [Related]  

  • 11. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 12. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer risk: is postmenopausal hormone therapy ever safe?
    Ganz PA
    Menopause; 2005; 12(6):653-5. PubMed ID: 16278604
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone replacement therapy for breast cancer survivors: an answered question?
    Zielinski SL
    J Natl Cancer Inst; 2005 Jul; 97(13):955. PubMed ID: 15998945
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
    Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
    J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?].
    Mathelin C; Brettes JP
    Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563
    [No Abstract]   [Full Text] [Related]  

  • 17. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised HRT trials in breast cancer survivors are justified.
    Marsden J
    Maturitas; 2003 Oct; 46(2):107-8. PubMed ID: 14559379
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F; Huiart L
    J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?".
    Dören M; Greiser EM
    Am J Epidemiol; 2007 Dec; 166(12):1479-80; author reply 1481-2. PubMed ID: 17977898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.